𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Combination of an EGFR blocker and a COX-2 inhibitor for the treatment of advanced cutaneous squamous cell carcinoma

✍ Scribed by Ahmad Jalili; Alice Pinc; Friederike Pieczkowski; Franz M. Karlhofer; Georg Stingl; Stephan N. Wagner

Book ID
111275606
Publisher
John Wiley and Sons
Year
2008
Tongue
German
Weight
278 KB
Volume
6
Category
Article
ISSN
1610-0379

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Combination chemotherapy for advanced sq
Combination chemotherapy for advanced squamous cell carcinoma of the head and neck
✍ Coker, Donald D. ;Elias, E. George ;Chretien, Paul B. ;Gray, William C. ;Coleman πŸ“‚ Article πŸ“… 1981 πŸ› Wiley (John Wiley & Sons) βš– 639 KB

## Abstract Fifty‐one patients (32 previously untreated, 19 previously treated) with advanced squamous cell carcinoma of the head and neck received a single course of combination chemotherapy consisting of high dose __cis__‐platinum (DDP), bleomycin (Bleo), Β± high dose methotrexate (MTX). Thirty‐th

The effects of a COX-2 inhibitor meloxic
The effects of a COX-2 inhibitor meloxicam on squamous cell carcinoma of the esophagus in vivo
✍ Jun-Feng Liu; Shao-Wei Zhang; Glyn G. Jamieson; Gui-Jun Zhu; Tie-Cheng Wu; Tie-N πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 French βš– 227 KB

## Abstract Our previous study showed that aspirin induced apoptosis of esophageal cancer cells __in vitro__ by inhibiting the pathway of NF‐kappaB downstream regulation of cyclooxygenase‐2. The purpose of this study was to determine if similar changes occurred __in vivo__ in the tumors of patients